Check out MSAA’s educational programs and special events.
Read News Article
Author: Hoff Communications
MSAA Draws Attention to Multiple Sclerosis Progression during MS Awareness Month
The organization will host a series of activities and events focused on providing education and raising awareness about multiple sclerosis during the month of March March is officially recognized as […]
Read News ArticleMultiple Sclerosis Awareness Month Videos
Changing Lives Monday to Sunday Multiple sclerosis never takes a day off. Neither does MSAA’s commitment to making a difference in the lives of people with MS. That is why […]
Read News ArticleMultiple Sclerosis Awareness Month 2018
March is Multiple Sclerosis Awareness Month, and MSAA is proud to support this national campaign with educational activities and events throughout the country. MSAA has focused 2018’s awareness campaign on […]
Read News ArticleAbout MS – Download PDF
– or – No thank you – download file only
Read News ArticleWellness Tips*
Exercise Exercise is key in maintaining function in people with MS. In addition to showing positive effects on walking speed, endurance, and aerobic capacity in MS, exercise can also lower […]
Read News ArticleHow MSAA Can Help
Information and Education MSAA’s website provides a wealth of information at mymsaa.org. This includes important news and timely updates, online videos, event listings, and more. Multiple Sclerosis Information (MSi) is […]
Read News ArticleMultiple Sclerosis Symptoms
MS has the potential to cause several different symptoms and the specific symptoms each person experiences vary greatly. When experiencing one or more of these symptoms, individuals should consult their […]
Read News ArticleThe FDA-Approved Long-Term Treatments for MS
The following chart includes the 16 disease-modifying therapies (DMTs) currently (at the time of printing) approved by the Food and Drug Administration (FDA) for the long-term treatment of MS. Additional […]
Read News ArticleThe Importance of Long-Term Treatment
Since the 1990s, the FDA-approved disease-modifying therapies (DMTs) were only available for individuals with relapsing forms of multiple sclerosis – largely for those with RRMS. However, in early 2017, a […]
Read News Article